Twist Bioscience

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Twist Bioscience 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About TWST

Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC. 

CEO
Emily Marine Leproust
CEOEmily Marine Leproust
Employees
979
Employees979
Headquarters
San Francisco, California
HeadquartersSan Francisco, California
Founded
2013
Founded2013
Employees
979
Employees979

TWST Key Statistics

Market cap
3.01B
Market cap3.01B
Price-Earnings ratio
-38.53
Price-Earnings ratio-38.53
Dividend yield
Dividend yield
Average volume
1.81M
Average volume1.81M
High today
$50.17
High today$50.17
Low today
$47.70
Low today$47.70
Open price
$48.30
Open price$48.30
Volume
1.06M
Volume1.06M
52 Week high
$51.00
52 Week high$51.00
52 Week low
$23.30
52 Week low$23.30

Stock Snapshot

Twist Bioscience(TWST) stock is priced at $47.70, giving the company a market capitalization of 3.01B. It carries a P/E multiple of -38.53.

On 2026-02-16, Twist Bioscience(TWST) stock moved within a range of $47.70 to $50.17. With shares now at $47.70, the stock is trading 0.0% above its intraday low and -4.9% below the session's peak.

Trading activity shows a volume of 1.06M, compared to an average daily volume of 1.81M.

Over the past 52 weeks, Twist Bioscience(TWST) stock has traded between a high of $51.00 and a low of $23.30.

Over the past 52 weeks, Twist Bioscience(TWST) stock has traded between a high of $51.00 and a low of $23.30.

TWST News

Simply Wall St 4d
Twist Bioscience Valuation Check After New Sequencing Kits Expand Genomics Offering

Twist Bioscience (TWST) has attracted fresh attention after launching its TrueAmp Library Preparation Kit and PCR Free WGS Library Preparation Kit, broadening i...

Twist Bioscience Valuation Check After New Sequencing Kits Expand Genomics Offering
The Motley Fool 5d
Biotech Beat Nvidia in 2025. Can It Do It Again?

Big pharma and biotech take the earnings stage with reports from Eli Lilly and Novo Nordisk leading the lineup. Will they help the industry once again outperfor...

Biotech Beat Nvidia in 2025. Can It Do It Again?
TipRanks 7d
Twist Bioscience Rocked by Fresh Insider Stock Move From Company Director

New insider activity at Twist Bioscience ( (TWST) ) has taken place on February 9, 2026. Director Jan Johannessen has reduced his stake in Twist Bioscience by...

Analyst ratings

82%

of 11 ratings
Buy
81.8%
Hold
18.2%
Sell
0%

People also own

Based on the portfolios of people who own TWST. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.